Bega, Danny
Kuo, Phillip H.
Chalkidou, Anastasia http://orcid.org/0000-0002-7519-8774
Grzeda, Mariusz T.
Macmillan, Thomas http://orcid.org/0000-0001-7274-797X
Brand, Christine
Sheikh, Zulfiqar H.
Antonini, Angelo
Funding for this research was provided by:
GE | GE Healthcare
Article History
Received: 30 September 2020
Accepted: 29 March 2021
First Online: 24 May 2021
Competing interests
: The authors declare the following competing interests: A.C., T.M. and M.G. received funding for this analysis from GE Healthcare and are employees of Kings College London. D.B., P.K. and A.A. have acted as consultants for GE Healthcare. P.K. has acted as a consultant, speaker and grant recipient for GE Healthcare and is an employee of Konica-Minolta. A.A. has received compensation for consultancy and speaker-related activities from UCB, Boehringer–Ingelheim, General Electric, Britannia, AbbVie, Kyowa Kirin, Zambon, Bial, Neuroderm, Theravance Biopharma, Roche; he receives research support from Chiesi Pharmaceuticals, Bial, Lundbeck, Horizon2020 - Grant 825785, Horizon2020 Grant 101016902, Ministry of Education University and Research (MIUR) Grant ARS01_01081, Cariparo Foundation. He serves as a consultant for Boehringer–Ingelheim for legal cases on pathological gambling. Z.H. and C.B. are employees of GE Healthcare.